# Xyall

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xyall-b-v

- Industry: Biotechnology
- Headquarters: Eindhoven, Netherlands
- Website: www.xyall.com
- Total disclosed funding: $6.4M
- Latest round: Series B (May 24, 2022)
- Investors on record: 3

## About

Based in Eindhoven, Netherlands, and co-founded by Guido du Pree (CEO) and Hans van Wijngaarden (COO) in 2018, Xyall B.V. operates as a biotechnology company that supports automation and digitization of the tissue dissection workflow. In February 2026, Xyall B.V. raised EUR 7.6 million in venture funding led by Capricorn Partners, with participation from Sioux Tech Fund, BOM Brabant Ventures, Health Investment Partners. 

The company integrates precision robotics, digital pathology, and workflow optimization to bridge the gap between histopathology and molecular pathology. Their Tissector solutions offer high accuracy, high throughput, and full quality control. Xyalls flagship products include the Tissector High Throughput (HT), Tissector Table Top (TT) solutions, and Tissector Annotation Suite (AS), designed to cater to the diverse needs of molecular diagnostic laboratories. HT offers continuous operation and is fully integrated with digital pathology solutions (IMS) and laboratory workflow management (LIMS) for high-volume molecular diagnostic laboratories. HT has a throughput capacity of 80 slides per hour, with a precision of 0.1 mm and 3 hours of uninterrupted operation time.  TT offers batch operation fully integrated with digital pathology solutions and the laboratory workflow (LIMS) for small to medium-sized molecular pathology laboratories. TT has a throughput capacity of 30 slides per hour, with a precision of 0.1 mm and of 2 hrs uninterrupted operation time. AS is a digital workstation that allows pathologists to remotely see and annotate cases with over 40 times magnification.

## Funding rounds

- Series B, May 24, 2022, $6.4M — BOM Brabant Ventures, Sioux Tech Fund, Health Investment Partners

## Investors

- BOM Brabant Ventures (https://capitalatlas.ai/funds/bom-brabant-ventures) — Series B
- Sioux Tech Fund — Series B
- Health Investment Partners (https://capitalatlas.ai/funds/health-investment-partners) — Series B